LabVantage Awarded US Army Contract for LIMS COVID-19 Vaccine Support

News
Article

The company will supply its LIMS to the Walter Reed Army Institute of Research (WRAIR) to support vaccine production programs for COVID-19 at WRAIR’s pilot bioproduction facility.

LabVantage Solutions, a provider of laboratory informatics solutions and services, announced on Oct. 13, 2020 that the US Army Medical Research Acquisition Activity has presented it with a contract to supply its LabVantage Pharma laboratory information management system (LIMS) to the Walter Reed Army Institute of Research (WRAIR) to support vaccine production programs for COVID-19 at WRAIR’s pilot bioproduction facility.

According to a LabVantage press release, the company’s LIMS package for pharmaceutical and biotech laboratories comes with batch management, stability testing, consumables management, environmental monitoring, barcode label printing, instrument calibration, certification, and maintenance.

“We developed LabVantage Pharma to make it fast and easy for pharmaceutical and biotech organizations to acquire and implement a state-of-the-art laboratory information management system to enable efficient and compliant quality manufacturing,” said John Heiser, CEO of LabVantage, in the press release. “We appreciate that WRAIR understood the unique benefits of LabVantage Pharma and moved to expedite its acquisition via a sole source contract. We are very proud that our purpose-built LIMS is now helping the WRAIR address the urgent need for new vaccines and therapies to combat COVID-19 and other serious diseases.”

Source: LabVantage

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content